Vladimir Zakharov As part of its 37th annual reconstitution, FTSE Russell announced preliminary additions and
Vladimir Zakharov Kicking off its 37th annual reconstitution, FTSE Russell has published preliminary lists of
Cassava Sciences press release (NASDAQ:SAVA): Q1 GAAP EPS of -$0.48. At March 31, 2025, cash
bankrx Cassava Sciences (NASDAQ:SAVA) announced on Monday the retirement of James W. Kupiec, Chief Medical
Melissa Kopka U.S. stock index futures were slightly higher on Tuesday, as Wall Street looked
travellinglight/iStock via Getty Images Cassava Sciences (NASDAQ:SAVA) lost ~19% in the premarket on Tuesday after
Cassava Sciences press release (NASDAQ:SAVA): Q4 GAAP EPS of -$0.57 beats by $0.09. At December
koto_feja/E+ via Getty Images Cassava Sciences (NASDAQ:SAVA) said on Thursday that it has signed a
tupungato Cassava Sciences (NASDAQ:SAVA) has formally ended its phase 3 REFOCUS-ALZ trial for Alzheimer’s asset
BrianAJackson Cassava Sciences (NASDAQ:SAVA) is laying off 33% of its workforce — 10 employees —